Treatment patterns and outcomes in advanced and metastatic lung cancer in France: Results from the Epidemiological Strategy and medical Economics (ESME) database lung cancer in France.

Fiche publication

Date publication

août 2026

Journal

Lung cancer (Amsterdam, Netherlands)

Auteurs

Membres identifiés du Cancéropôle Est :
Dr DEBIEUVRE Didier , Dr SCHOTT Roland

Tous les auteurs :
Girard N, Carton M, Macouillard P, Debieuvre D, Quantin X, Audigier-Valette C, Léna H, Filleron T, Gervais R, Schott R, Remon J, Justeau G, Bosquet L, Martin AL, Chouaid C, Pérol M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/42660015

Résumé

Lung cancer is the main cause of cancer-related death, with recent paradigm shifts including optimized staging, identification of molecular subsets with access to targeted agents, and replacement of chemotherapy by immunotherapy as the backbone of treatment. The Lung Cancer part of the Epidemiological Strategy and Medical Economics (ESME) research program was launched to collect individual data from all consecutive patients treated for lung cancer since 2015 in a network of 38 health facilities in France.